<?xml version="1.0" encoding="UTF-8"?>
<p id="par0145">The activities of SOD (3.30 ± 0.35 U/mg), catalase (833.98 ± 154.66 U/mg), GPx (250.88 ± 18.11 nmol/min/mg), GR (12.59 ± 1.86 nmol/min/mg), and GST (10.58 ± 1.62 nmol/min/mg) in the APAP group were decreased compared to those in the control group (
 <xref rid="fig0025" ref-type="fig">Fig. 5</xref> and Supplementary data 1, 
 <italic>P</italic> &lt; 0.05). Conversely, treatment with 1400 mg/kg/day GMSYS significantly increased the activities of SOD (4.55 ± 0.16 U/mg, 
 <xref rid="fig0025" ref-type="fig">Fig. 5</xref>a), catalase (3172.76 ± 359.08 U/mg, 
 <xref rid="fig0025" ref-type="fig">Fig. 5</xref>b), GPx (481.82 ± 25.37 nmol/min/mg, 
 <xref rid="fig0025" ref-type="fig">Fig. 5</xref>c), GR (21.18 ± 1.01 nmol/min/mg, 
 <xref rid="fig0025" ref-type="fig">Fig. 5</xref>d), and GST (22.61 ± 1.90 nmol/min/mg, 
 <xref rid="fig0025" ref-type="fig">Fig. 5</xref>e) compared to that in the APAP group (
 <italic>P</italic> &lt; 0.01). Meanwhile, the catalase activity tended to increase in 700 mg/kg/day GMSYS-treated group (2078.50 ± 358.95 U/mg) compared to the APAP group, but there was no significance. Additionally, there was no difference in the activities of SOD (3.02 ± 0.19 U/mg), GPx (282.30 ± 23.11 nmol/min/mg), GR (13.78 ± 1.48 nmol/min/mg), and GST (10.32 ± 1.08 nmol/min/mg) between the APAP group and 700 mg/kg/day GMSYS-treated group. Silymarin increased the activities of SOD (4.01 ± 0.70 U/mg), catalase (1279.58 ± 95.83 U/mg), and GST (16.65 ± 1.54 nmol/min/mg) compared to that in the APAP group, but not significantly. The activities of GPx (407.08 ± 30.89 nmol/min/mg, 
 <italic>P</italic> &lt; 0.01) and GR (18.71 ± 1.36 nmol/min/mg, 
 <italic>P</italic> &lt; 0.05) significantly increased by administration with silymarin compared to that in the APAP group.
</p>
